This is a firm-fixed-price purchase order awarded by the Bureau of Medicine and Surgery (part of the U.S. Navy) to Biomerieux Inc. for the procurement of Biomerieux EMAG reagents. The contract has a period of performance through April 8, 2025 and a ceiling value of $28,840.20. The requirement was sole-sourced to Biomerieux as the only known provider of the EMAG reagents needed by the Naval Health Research Center (NHRC) in San Diego. This purchase order is likely part of a larger Indefinite...
This is a $235,020.16 firm fixed price purchase order awarded by the Defense Health Agency to Biomerieux Inc., a foreign-owned, for-profit manufacturer of diagnostic goods. The contract is for pathogenic bacteria cost per reportable, with a completion date of June 30, 2023. The original solicitation requested responses in the prescribed SF1449 format, with pricing on the provided contract line items. Biomerieux Inc. is a leading global provider of in vitro diagnostic solutions, including...
This firm fixed-price purchase order was awarded by the Defense Health Agency to Biomerieux Inc., a foreign-owned, for-profit manufacturer of medical diagnostic products. The $134,850.96 contract is for the provision of a BACT/ALERT 3D 1200 microbiology analysis system, along with associated maintenance and support services, to be performed in San Diego, California. The contract has a performance period through September 30, 2023. Biomerieux Inc. is an experienced federal contractor, having...
This is a firm-fixed-price delivery order awarded by the Bureau of Medicine and Surgery, a component of the Department of Defense, to Biomerieux Inc. for a "Cost Per Test Laboratory Mass Spectrometer". The contract has a ceiling value of $101,033.92 and a period of performance ending on March 22, 2016. The contract does not have a set-aside designation. Biomerieux Inc., a global leader in in vitro diagnostics, is the prime contractor and has supplied its proprietary VITEK systems and...
This is a $118,724 firm fixed price purchase order awarded to Biomerieux Inc. by the Department of Veterans Affairs (VA) Veterans Health Administration, Veterans Integrated Service Network 6. The contract is for the EASYMAG SYSTEM, with a performance period ending on September 30, 2020. This award was not set aside for any socioeconomic program. Biomerieux Inc. is a foreign-owned, for-profit manufacturer of in vitro diagnostic products and solutions. The company has a history of federal contract...
This is a firm-fixed-price purchase order awarded to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of BioMerieux BACT/ALERT 3D and 3D automated blood culture system supplies and services. The $11,058.64 contract was awarded by the Defense Health Agency, a defense agency, with an ultimate completion date of October 1, 2024. The award does not involve any set-aside designation. Biomerieux Inc., through its Biomerieux, Inc. division, is the prime contractor for this...
This is a delivery order awarded to Biomerieux Inc., a global leader in in vitro diagnostics, under the Multiple Award Schedule (MAS) contract vehicle. The contract is for the supply of a VITEK 60 COMPACT diagnostic instrument, valued at $71,738.04, with a period of performance ending on September 30, 2024. The contract was awarded by the Bureau of Medicine and Surgery, a component of the Department of Defense, to support its healthcare operations. Biomerieux is a sole-source provider for this...
This is a firm-fixed-price purchase order awarded by the U.S. Army Medical Command (MEDCOM) to Biomerieux Inc., a global leader in in vitro diagnostics. The contract, valued at $16,879.50, is for the provision of Biomerieux's proprietary diagnostic platforms, reagents, and test kits to support the agency's infectious disease testing and pathogen detection requirements. The contract does not have a set-aside designation, as Biomerieux is often the sole source provider for its specialized...
This is a firm fixed-price purchase order awarded by the Department of the Army Medical Command to Biomerieux Inc., a foreign-owned, for-profit manufacturer of goods, for the provision of a microbiology analyzer and associated maintenance and supplies. The contract has a potential value of $105,805.80 and a completion date of October 31, 2023. No set-aside designation is mentioned. Biomerieux Inc. is a worldwide leader in in vitro diagnostics, offering clinical testing solutions and equipment,...
This is a firm-fixed-price delivery order awarded to Biomerieux Inc. by the Office of Administrative Services Procurement Management Branch, a civilian agency, for the provision of Biomerieux's Campylobacter Gene-UP diagnostic test systems and related services. The $60,825.60 task order is placed against Biomerieux's existing $194 million Federal Supply Schedule contract for In Vitro Diagnostics, Reagents, and Test Kits, which allows various government agencies to procure the company's...